Detalles de la búsqueda
1.
Tofacitinib Appears Well Tolerated and Effective for the Treatment of Patients with Refractory Crohn's Disease.
Dig Dis Sci
; 67(8): 4043-4048, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35288831
2.
Efficacy of Infliximab in Crohn's Disease Patients with Prior Primary-Nonresponse to Tumor Necrosis Factor Antagonists.
Dig Dis Sci
; 64(7): 1952-1958, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30815825
3.
Case Series: Re-induction of Intravenous, Weight-Based Ustekinumab Is Well Tolerated in Patients With Moderate-Severe Crohn's Disease.
Crohns Colitis 360
; 4(2): otac012, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36777048
4.
Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease.
Inflamm Bowel Dis
; 28(2): 309-313, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34347103
Resultados
1 -
4
de 4
1
Próxima >
>>